Adverse event profile
ADVERSE EVENTS, ADVERSE EFFECTS
Twenty-one patients (95.4%) experienced adverse effects during the study regimen, including 7 (31.8%) with grade 3 or worse adverse events (Table Profile of the adverse events noted in the study population